Evaluation of the correctable decoding sequencing as a new powerful strategy for DNA sequencing

Next-generation sequencing (NGS) promises to revolutionize precision medicine, but the existing sequencing technologies are limited in accuracy. To overcome this limitation, we propose the correctable decoding sequencing strategy, which is a duplex sequencing protocol with conservative theoretical error rates of 0.0009%. This rate is lower than that for Sanger sequencing. Here, we simulate the sequencing reactions by the self-developed software, and find that this approach has great potential in NGS in terms of sequence decoding, reassembly, error correction, and sequencing accuracy. Besides, this approach can be compatible with most SBS-based sequencing platforms, and also has the ability to compensate for some of the shortcomings of NGS platforms, thereby broadening its application for researchers. Hopefully, it can provide a powerful new protocol that can be used as an alternative to the existing NGS platforms, enabling accurate identification of rare mutations in a variety of applications in biology and medicine.

Automated summary

Next-generation sequencing holds great potential for precision medicine, but current technologies have limitations in accuracy. To overcome this, a correctable decoding sequencing strategy with conservative error rates is proposed. This strategy shows promise in sequence decoding, error correction, and sequencing accuracy, and can be used as an alternative to existing NGS platforms.